{"id":24718,"date":"2023-12-12T09:57:00","date_gmt":"2023-12-12T09:57:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=24718"},"modified":"2026-03-19T14:59:13","modified_gmt":"2026-03-19T21:59:13","slug":"vyvgart-an-effective-treatment-for-myasthenia-gravis","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/","title":{"rendered":"Vyvgart: Un tratamiento eficaz para la miastenia grave"},"content":{"rendered":"<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/myasthenia-gravis\/\">Miastenia gravis (MG)<\/a>&nbsp;Es un trastorno neuromuscular poco com\u00fan y potencialmente mortal en el que los m\u00fasculos esquel\u00e9ticos se debilitan con el tiempo. Es una enfermedad autoinmune a largo plazo causada por el deterioro del contacto regular entre nervios y m\u00fasculos. La MG afecta la mayor\u00eda de las partes del cuerpo, pero generalmente se propaga desde los ojos y la cara a otras zonas.<\/p>\n\n\n\n<p>Aunque la miastenia gravis no afecta significativamente la esperanza de vida de la mayor\u00eda de las personas, los pacientes afectados tienen mayor probabilidad de presentar una disminuci\u00f3n de la actividad f\u00edsica y una menor calidad de vida. Las investigaciones revelan que aproximadamente 20 de cada 100.000 personas padecen MG.<\/p>\n\n\n\n<p>Sin embargo, la buena noticia es que existen tratamientos que pueden ayudar a mantener los s\u00edntomas bajo control. Vyvgart es una de las opciones de terapia para MG altamente recomendadas que est\u00e1 cambiando el panorama.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#What_Is_Vyvgart\" >\u00bfQu\u00e9 es Vyvgart?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#How_Does_Vyvgart_Work\" >\u00bfC\u00f3mo funciona Vyvgart?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Treatment\" >Tratamiento<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#How_to_Take_Vyvgart\" >C\u00f3mo tomar Vyvgart<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Dosing\" >Dosificaci\u00f3n<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Overdose\" >Sobredosis<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Side_Effects\" >Efectos secundarios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Precautions\" >Precauciones<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Fertility\" >Fertilidad<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Pregnancy\" >Embarazo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Breast-feeding\" >Amamantamiento<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Drug_Interactions\" >Interacciones farmacol\u00f3gicas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Vyvgart_Storage_Conditions\" >Condiciones de almacenamiento del Vyvgart<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#Vyvgart_Cost\" >Costo del Vyvgart<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-vyvgart\"><span class=\"ez-toc-section\" id=\"What_Is_Vyvgart\"><\/span>\u00bfQu\u00e9 es Vyvgart?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Vyvgart (efgartigimod) es un medicamento recetado que se usa para tratar a adultos con diagn\u00f3stico de miastenia gravis generalizada (gMG) y que son positivos para anticuerpos del receptor de acetilcolina (AChR).<\/p>\n\n\n\n<p>Curiosamente es la primera&nbsp;<a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-myasthenia-gravis\">Tratamiento aprobado por la FDA<\/a>&nbsp;Este medicamento utiliza un anticuerpo IgG cristalizado en fragmentos para el tratamiento de adultos con anticuerpos anti-AChR positivos. La Administraci\u00f3n de Alimentos y Medicamentos de EE. UU. (FDA) aprob\u00f3 el Vyvgart para el tratamiento de la miastenia gravis (MGg) en diciembre de 2021. Contiene efgartigimod alfa y puede usarse de forma independiente o en combinaci\u00f3n con otros medicamentos.&nbsp;<\/p>\n\n\n\n<p>Un mayor&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03669588\">estudio cl\u00ednico<\/a>&nbsp;Un estudio con poco m\u00e1s de cien pacientes con gMG y anticuerpos AChR positivos revel\u00f3 que el Vyvgart fue eficaz para mejorar los s\u00edntomas de la enfermedad. Este estudio analiz\u00f3 la eficacia del medicamento mediante una escala de actividades de la vida diaria espec\u00edficas para la miastenia gravis (MG-AVD), que mide el impacto de la enfermedad en las actividades diarias del paciente. La escala se basa en n\u00fameros, y los n\u00fameros m\u00e1s altos indican s\u00edntomas m\u00e1s graves.<\/p>\n\n\n\n<p>En este estudio, tras el primer ciclo de tratamiento, aproximadamente 68% de los pacientes tratados con Vyvgart experimentaron una mejora considerable, en comparaci\u00f3n con aproximadamente 30% de los pacientes tratados con placebo. Un mayor n\u00famero de pacientes que recibieron Vyvgart tambi\u00e9n indic\u00f3 una respuesta en la medici\u00f3n de la debilidad muscular.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-vyvgart-work\"><span class=\"ez-toc-section\" id=\"How_Does_Vyvgart_Work\"><\/span>\u00bfC\u00f3mo funciona Vyvgart?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Nuestros nervios regulan la acci\u00f3n de nuestros m\u00fasculos.&nbsp;<a href=\"https:\/\/my.clevelandclinic.org\/health\/articles\/24568-acetylcholine-ach\">Acetilcolina<\/a>&nbsp;Se descarga de un nervio cuando un m\u00fasculo se contrae y se une a los receptores de acetilcolina (AChR) en las c\u00e9lulas musculares.<\/p>\n\n\n\n<p>En pacientes con gMG, el sistema inmunitario produce autoanticuerpos (prote\u00ednas que da\u00f1an por error partes del cuerpo) que da\u00f1an estos receptores. Como resultado de este da\u00f1o, los m\u00fasculos no pueden contraerse con normalidad, lo que provoca debilidad muscular y complicaciones en el movimiento.<\/p>\n\n\n\n<p>El Vyvgart act\u00faa uni\u00e9ndose a una prote\u00edna llamada receptor Fc neonatal (FcRn), que regula los niveles de anticuerpos en la sangre e inhibe su acci\u00f3n. Al bloquear el FcRn, el Vyvgart reduce el nivel de autoanticuerpos. Esto, a su vez, mejora la capacidad de contracci\u00f3n muscular y disminuye los s\u00edntomas de la enfermedad.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-treatment\"><span class=\"ez-toc-section\" id=\"Treatment\"><\/span>Tratamiento<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Debido a la naturaleza de su acci\u00f3n, el Vyvgart se recomienda especialmente para pacientes con miastenia gravis generalizada con anticuerpos anti-AChR positivos. El tratamiento de la gMG puede ayudar a aliviar los s\u00edntomas para que los pacientes puedan llevar una vida pr\u00e1cticamente normal.<\/p>\n\n\n\n<p>Sin embargo, algunas personas requieren un tratamiento continuo y el tratamiento de emergencia peri\u00f3dico en un hospital puede ser crucial si la condici\u00f3n empeora inesperadamente.&nbsp;<\/p>\n\n\n\n<p>Aunque la mayor\u00eda de los pacientes con miastenia gravis generalizada son AChR positivos, es recomendable que su m\u00e9dico determine si usted es positivo para anticuerpos anti-AChR. Esto ayudar\u00eda a prevenir complicaciones derivadas de un diagn\u00f3stico o tratamiento err\u00f3neo.&nbsp;<\/p>\n\n\n\n<p>El Vyvgart est\u00e1 disponible como infusi\u00f3n intravenosa (goteo). Tras evaluar la respuesta del paciente al tratamiento, el personal sanitario decidir\u00e1 la cantidad de ciclos a administrar.<\/p>\n\n\n\n<p>Los pacientes pueden recibir tratamiento para la miastenia gravis (MG) con medicamentos, cirug\u00eda y otras terapias. Es recomendable que hable sobre sus inquietudes y antecedentes m\u00e9dicos con sus m\u00e9dicos, ya que la mejor&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/myasthenia-gravis-treatment-options\/\">opci\u00f3n de tratamiento<\/a>&nbsp;Para usted depender\u00e1 de la gravedad de la enfermedad, los m\u00fasculos afectados, la edad y la existencia de otras condiciones m\u00e9dicas.&nbsp;<\/p>\n\n\n\n<p>El Vyvgart no est\u00e1 disponible como medicamento de venta libre, y se requiere cierta experiencia para su manejo. Su administraci\u00f3n debe ser realizada por personal m\u00e9dico con experiencia en el manejo de pacientes con trastornos neuromusculares.&nbsp;<\/p>\n\n\n\n<p>El tratamiento de la miastenia gravis tambi\u00e9n incorpora el cuidado personal, que incluye dormir lo suficiente, regular el nivel de actividad, comer alimentos saludables, hacer ejercicio y controlar el estr\u00e9s.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-to-take-vyvgart\"><span class=\"ez-toc-section\" id=\"How_to_Take_Vyvgart\"><\/span>C\u00f3mo tomar Vyvgart<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Los viales Vyvgart deben ser administrados mediante infusi\u00f3n intravenosa por un especialista sanitario.<\/li>\n\n\n\n<li>Examine visualmente la soluci\u00f3n diluida de Vyvgart para detectar impurezas o decoloraci\u00f3n antes de su administraci\u00f3n.<\/li>\n\n\n\n<li>Evite su uso si est\u00e1 descolorido o si se detectan contaminantes.<\/li>\n\n\n\n<li>Infundir 125 ml de soluci\u00f3n diluida por v\u00eda intravenosa durante una hora a trav\u00e9s de un filtro en l\u00ednea de 0,2 micrones.<\/li>\n\n\n\n<li>Despu\u00e9s de administrar Vyvgart, utilice&nbsp;<a href=\"https:\/\/www.webmd.com\/drugs\/2\/drug-145556\/sodium-chloride-0-9-intravenous\/details\">Inyecci\u00f3n de cloruro de sodio 0.9%<\/a>USP para limpiar toda la l\u00ednea.<\/li>\n<\/ul>\n\n\n\n<p>Se debe vigilar a los pacientes durante la administraci\u00f3n y durante una hora despu\u00e9s para detectar signos y s\u00edntomas cl\u00ednicos de reacciones de hipersensibilidad. Si se produce una reacci\u00f3n de hipersensibilidad durante la administraci\u00f3n, se debe suspender la administraci\u00f3n de Vyvgart e iniciar las medidas de soporte adecuadas.<\/p>\n\n\n\n<p>No se deben inyectar otros medicamentos en los puertos de infusi\u00f3n ni combinarlos con Vyvgart.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosing\"><span class=\"ez-toc-section\" id=\"Dosing\"><\/span>Dosificaci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La dosis de Vyvgart depende del peso del paciente. El f\u00e1rmaco se administra una vez por semana durante ciclos de 4 semanas.&nbsp;<\/p>\n\n\n\n<p>Su proveedor de atenci\u00f3n m\u00e9dica decidir\u00e1 cu\u00e1ntos ciclos administrarle despu\u00e9s de considerar c\u00f3mo reacciona al tratamiento.<\/p>\n\n\n\n<p>Generalmente, la dosis recomendada es de 10 mg\/kg para infusi\u00f3n intravenosa. Si el paciente pesa m\u00e1s de 120 kg, la dosis recomendada de Vyvgart es de 1200 mg por infusi\u00f3n.<\/p>\n\n\n\n<p>Si omite una infusi\u00f3n programada, administre Vyvgart hasta 3 d\u00edas despu\u00e9s de la hora programada. Posteriormente, retome la pauta posol\u00f3gica original hasta finalizar el ciclo de tratamiento.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-overdose\"><span class=\"ez-toc-section\" id=\"Overdose\"><\/span>Sobredosis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Aunque no se han detectado signos ni s\u00edntomas espec\u00edficos de sobredosis con Vyvgart, se debe vigilar a los pacientes para detectar reacciones adversas e iniciar el tratamiento sintom\u00e1tico y de soporte adecuado. Cabe destacar que no existe un ant\u00eddoto espec\u00edfico para la sobredosis con Vyvgart.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Efectos secundarios<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los efectos secundarios comunes pueden incluir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Infecci\u00f3n del tracto urinario (ITU)&nbsp;<\/li>\n\n\n\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>Infecci\u00f3n del tracto respiratorio&nbsp;<\/li>\n\n\n\n<li>S\u00edntomas del resfriado como congesti\u00f3n nasal, estornudos y dolor de garganta.<\/li>\n<\/ul>\n\n\n\n<p>Pueden presentarse otros efectos secundarios adem\u00e1s de los mencionados. No dude en contactar a su profesional de la salud o solicitar asistencia m\u00e9dica de emergencia si observa cualquier signo de reacci\u00f3n al\u00e9rgica, como dolor muscular, dificultad para respirar e hinchaz\u00f3n de la cara o los labios.<\/p>\n\n\n\n<p>Adem\u00e1s, contacte a su m\u00e9dico de inmediato si detecta signos de infecci\u00f3n, como fiebre, escalofr\u00edos, dolor de garganta, dolores corporales, cansancio inusual, p\u00e9rdida de apetito, hematomas o sangrado.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-precautions\"><span class=\"ez-toc-section\" id=\"Precautions\"><\/span>Precauciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-fertility\"><span class=\"ez-toc-section\" id=\"Fertility\"><\/span>Fertilidad<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>No existen datos disponibles sobre el efecto del Vyvgart en la fertilidad humana. Estudios en animales no han mostrado ning\u00fan impacto del Vyvgart en la fertilidad masculina ni femenina.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-pregnancy\"><span class=\"ez-toc-section\" id=\"Pregnancy\"><\/span>Embarazo<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>No hay datos disponibles sobre el uso de Vyvgart durante&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/myasthenia-gravis-in-pregnancy\/\">embarazo<\/a>Sin embargo, los anticuerpos que contienen anticuerpos monoclonales terap\u00e9uticos se transportan a trav\u00e9s de la placenta uni\u00e9ndose al FcRn.<\/p>\n\n\n\n<p>El Vyvgart puede transmitirse de la madre al feto, ya que se espera que reduzca los niveles de anticuerpos maternos, inhiba la transferencia de anticuerpos maternos al feto y reduzca la protecci\u00f3n pasiva del reci\u00e9n nacido. Antes de administrar el medicamento, su m\u00e9dico debe evaluar los riesgos y beneficios, y solo debe considerarlo si los beneficios cl\u00ednicos superan los riesgos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-breast-feeding\"><span class=\"ez-toc-section\" id=\"Breast-feeding\"><\/span>Amamantamiento<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>No existe informaci\u00f3n sobre la presencia de Vyvgart en la leche materna, sus efectos en el lactante ni en la producci\u00f3n de leche. No se han realizado estudios en animales sobre la transferencia de Vyvgart a la leche materna, por lo que no se puede descartar su excreci\u00f3n en la leche materna. El tratamiento con Vyvgart en mujeres lactantes solo debe considerarse si el beneficio cl\u00ednico supera los riesgos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-drug-interactions\"><span class=\"ez-toc-section\" id=\"Drug_Interactions\"><\/span>Interacciones farmacol\u00f3gicas<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Aunque se han realizado pocos o ning\u00fan estudio de interacci\u00f3n, Vyvgart puede disminuir las concentraciones de compuestos que se unen al receptor Fc neonatal humano (FcRn). Estos incluyen anticuerpos monoclonales, productos de inmunoglobulina o derivados de anticuerpos que contienen el dominio Fc humano de la subclase IgG.<\/p>\n\n\n\n<p>Se recomienda evitar tomar Vyvgart junto con tratamientos que incluyan los productos mencionados hasta un par de semanas despu\u00e9s de la \u00faltima dosis de cualquier ciclo de tratamiento con Vyvgart. Los pacientes que reciban Vyvgart durante el tratamiento con estos productos deben ser monitoreados cuidadosamente por sus profesionales de la salud para determinar la eficacia prevista de dichos productos.<\/p>\n\n\n\n<p>Para los pacientes que reciben tratamiento con Vyvgart, no se recomienda la vacunaci\u00f3n con vacunas vivas o atenuadas. Esto se debe a que Vyvgart causa una reducci\u00f3n en&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/immunoglobulin-igg-deficiency\/\">inmunoglobulina G<\/a>&nbsp;Niveles de (IgG).<\/p>\n\n\n\n<p>Todas las vacunas deben administrarse de acuerdo con las pautas de inmunizaci\u00f3n al menos cuatro semanas antes del inicio de un ciclo de tratamiento y no hasta dos semanas despu\u00e9s de la \u00faltima infusi\u00f3n de un ciclo de tratamiento.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-vyvgart-storage-conditions\"><span class=\"ez-toc-section\" id=\"Vyvgart_Storage_Conditions\"><\/span>Condiciones de almacenamiento del Vyvgart<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Debido a la falta de conservantes en Vyvgart, la administraci\u00f3n debe realizarse inmediatamente despu\u00e9s de la diluci\u00f3n y la ingesta debe finalizar dentro de las 4 horas.<\/p>\n\n\n\n<p>En los casos en que no sea posible el uso instant\u00e1neo del medicamento, la soluci\u00f3n diluida deber\u00e1 conservarse refrigerada entre 2\u00b0C y 8\u00b0C (36\u00b0F y 46\u00b0F) hasta por 8 horas.&nbsp;<\/p>\n\n\n\n<p>Proteja el medicamento de la luz y no lo congele. Deje que el medicamento diluido alcance la temperatura ambiente antes de administrarlo y complete la infusi\u00f3n dentro de las 4 horas siguientes a su extracci\u00f3n del refrigerador. Salvo que est\u00e9 expuesto al aire ambiente, no exponga el medicamento diluido al calor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-vyvgart-nbsp-cost\"><span class=\"ez-toc-section\" id=\"Vyvgart_Cost\"><\/span>Costo del Vyvgart<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El costo de Vyvgart puede variar seg\u00fan la farmacia. En la mayor\u00eda de los lugares, el precio de la soluci\u00f3n de Vyvgart (400 mg\/20 ml) es de aproximadamente $6275 por un suministro de 20 ml.<\/p>","protected":false},"excerpt":{"rendered":"<p>La miastenia gravis (MG) es un trastorno neuromuscular poco frecuente y potencialmente mortal en el que los m\u00fasculos esquel\u00e9ticos se debilitan con el tiempo. Se trata de una enfermedad autoinmune cr\u00f3nica causada por el deterioro del contacto normal entre los nervios y los m\u00fasculos.<\/p>","protected":false},"author":25,"featured_media":24719,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[64],"tags":[],"class_list":["post-24718","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-discontinued"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vyvgart: An Effective Treatment for Myasthenia Gravis - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about Vyvgart and how it treats myasthenia gravis. Topics include how the drug works, side effects, precautions, dosing, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vyvgart: An Effective Treatment for Myasthenia Gravis - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about Vyvgart and how it treats myasthenia gravis. Topics include how the drug works, side effects, precautions, dosing, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-12T09:57:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T21:59:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"Vyvgart: An Effective Treatment for Myasthenia Gravis\",\"datePublished\":\"2023-12-12T09:57:00+00:00\",\"dateModified\":\"2026-03-19T21:59:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/\"},\"wordCount\":1533,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg\",\"articleSection\":[\"Discontinued\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/\",\"name\":\"Vyvgart: An Effective Treatment for Myasthenia Gravis - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg\",\"datePublished\":\"2023-12-12T09:57:00+00:00\",\"dateModified\":\"2026-03-19T21:59:13+00:00\",\"description\":\"Learn about Vyvgart and how it treats myasthenia gravis. Topics include how the drug works, side effects, precautions, dosing, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Effective Treatment for Myasthenia Gravis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/vyvgart-an-effective-treatment-for-myasthenia-gravis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vyvgart: An Effective Treatment for Myasthenia Gravis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vyvgart: Un tratamiento eficaz para la miastenia gravis - AmeriPharma\u00ae Specialty Care","description":"Inf\u00f3rmese sobre el Vyvgart y c\u00f3mo trata la miastenia gravis. Se abordar\u00e1n temas como su mecanismo de acci\u00f3n, efectos secundarios, precauciones, dosificaci\u00f3n y mucho m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/","og_locale":"es_MX","og_type":"article","og_title":"Vyvgart: An Effective Treatment for Myasthenia Gravis - AmeriPharma\u00ae Specialty Care","og_description":"Learn about Vyvgart and how it treats myasthenia gravis. Topics include how the drug works, side effects, precautions, dosing, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-12-12T09:57:00+00:00","article_modified_time":"2026-03-19T21:59:13+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"Vyvgart: An Effective Treatment for Myasthenia Gravis","datePublished":"2023-12-12T09:57:00+00:00","dateModified":"2026-03-19T21:59:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/"},"wordCount":1533,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg","articleSection":["Discontinued"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/","url":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/","name":"Vyvgart: Un tratamiento eficaz para la miastenia gravis - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg","datePublished":"2023-12-12T09:57:00+00:00","dateModified":"2026-03-19T21:59:13+00:00","description":"Inf\u00f3rmese sobre el Vyvgart y c\u00f3mo trata la miastenia gravis. Se abordar\u00e1n temas como su mecanismo de acci\u00f3n, efectos secundarios, precauciones, dosificaci\u00f3n y mucho m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg","width":1280,"height":853,"caption":"Effective Treatment for Myasthenia Gravis"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/vyvgart-an-effective-treatment-for-myasthenia-gravis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Vyvgart: An Effective Treatment for Myasthenia Gravis"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Dr. Mark Alfonso, PharmD, BCMTMS","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"El Dr. Mark Alfonso, doctor en farmacia, naci\u00f3 y creci\u00f3 en Pueblo, Colorado. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Colorado, en el Campus M\u00e9dico Anschutz, en 2010. Obtuvo su certificaci\u00f3n en gesti\u00f3n de terapias farmacol\u00f3gicas en 2022. Lo m\u00e1s gratificante de su trabajo es ayudar a responder las preguntas e inquietudes de los pacientes. Sus \u00e1reas de especializaci\u00f3n son la farmacia comunitaria y la gesti\u00f3n de terapias farmacol\u00f3gicas. En su tiempo libre, disfruta de la lectura y correr.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Myasthenia gravis (MG) is a rare and potentially lethal neuromuscular disorder in which the skeletal muscles weaken as time passes. It is a long-term autoimmune condition caused by deterioration in the regular contact between nerves and muscles.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/Vyvgart-An-Effective-Treatment-for-Myasthenia-Gravis.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/discontinued\/\" rel=\"category tag\">Discontinued<\/a>","rttpg_excerpt":"Myasthenia gravis (MG) is a rare and potentially lethal neuromuscular disorder in which the skeletal muscles weaken as time passes. It is a long-term autoimmune condition caused by deterioration in the regular contact between nerves and muscles.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=24718"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24718\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/24719"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=24718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=24718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=24718"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}